BRA
ABBV icon

Bender Robert & Associates’s AbbVie ABBV Stock Holding History

Bender Robert & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,466
Closed -$1.28M – 41
2024
Q2 		$1.28M Buy
+7,466
New +$1.24M 0.28% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bender Robert & Associates's ABBV Position: Q2 2026 in Review

Bender Robert & Associates held its AbbVie (ABBV) position steady in Q2 2026 at 2,393 shares worth $602K. The position accounts for 0.13% of the portfolio, ranked #30.

Bender Robert & Associates first reported a position in ABBV in Q2 2015 and has held it in 44 quarters since. The position peaked at $5.61M in Q4 2017. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bender Robert & Associates held 2,393 shares of AbbVie worth $602K as of Q2 2026.
  • Bender Robert & Associates left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.13% of Bender Robert & Associates's portfolio in Q2 2026, its #30 holding.
  • Bender Robert & Associates first reported a position in AbbVie in Q2 2015 and has held it in 44 quarters since.
  • Bender Robert & Associates's AbbVie position peaked at $5.61M in Q4 2017.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bender Robert & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.